Selected research
Market Analysis & Forecast
Global Sodium Iodine (131I) Drugs Market Analysis and Forecast 2026-2032
Market perspective
The global Sodium Iodine (131I) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sodium Iodine (131I) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Sodium Iodine (131I) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Sodium Iodine (131I) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Sodium Iodine (131I) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Sodium Iodine (131I) Drugs include Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Chengdu Gaotong Isotope Co.,Ltd., Mallinckrodt, Jubilant Radiopharma, International Isotopes, BWXT Medical Ltd, Bracco and AnazaoHealth, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Sodium Iodine (131I) Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Sodium Iodine (131I) Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Sodium Iodine (131I) Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sodium Iodine (131I) Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sodium Iodine (131I) Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sodium Iodine (131I) Drugs sales, projected growth trends, production technology, application and end-user industry.
Sodium Iodine (131I) Drugs Segment by Company
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Chengdu Gaotong Isotope Co.,Ltd.
Mallinckrodt
Jubilant Radiopharma
International Isotopes
BWXT Medical Ltd
Bracco
AnazaoHealth
Sodium Iodine (131I) Drugs Segment by Type
Sodium Iodine [131I] Capsules
Sodium iodine [131I] Oral Solution
Sodium Iodine (131I) Drugs Segment by Application
Diagnosis and Investigation
Thyroid Cancer
Hyperthyroidism
Sodium Iodine (131I) Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Iodine (131I) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Iodine (131I) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Iodine (131I) Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Sodium Iodine (131I) Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sodium Iodine (131I) Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sodium Iodine (131I) Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sodium Iodine [131I] Capsules
- Sodium iodine [131I] Oral Solution
Applications
- Diagnosis and Investigation
- Thyroid Cancer
- Hyperthyroidism
Companies covered
- Hta Co., Ltd
- Yantai Dongcheng Biochemicals Co.,Ltd.
- Chengdu Gaotong Isotope Co.,Ltd.
- Mallinckrodt
- Jubilant Radiopharma
- International Isotopes
- BWXT Medical Ltd
- Bracco
- AnazaoHealth
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Sodium Iodine (131I) Drugs Market by Type
- 1.2.1 Global Sodium Iodine (131I) Drugs Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Sodium Iodine [131I] Capsules
- 1.2.3 Sodium iodine [131I] Oral Solution
- 1.3 Sodium Iodine (131I) Drugs Market by Application
- 1.3.1 Global Sodium Iodine (131I) Drugs Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Diagnosis and Investigation
- 1.3.3 Thyroid Cancer
- 1.3.4 Hyperthyroidism
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sodium Iodine (131I) Drugs Market Dynamics
- 2.1 Sodium Iodine (131I) Drugs Industry Trends
- 2.2 Sodium Iodine (131I) Drugs Industry Drivers
- 2.3 Sodium Iodine (131I) Drugs Industry Opportunities and Challenges
- 2.4 Sodium Iodine (131I) Drugs Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Sodium Iodine (131I) Drugs Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Sodium Iodine (131I) Drugs Revenue by Region
- 3.2.1 Global Sodium Iodine (131I) Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Sodium Iodine (131I) Drugs Revenue by Region (2021-2026)
- 3.2.3 Global Sodium Iodine (131I) Drugs Revenue by Region (2027-2032)
- 3.2.4 Global Sodium Iodine (131I) Drugs Revenue Market Share by Region (2021-2032)
- 3.3 Global Sodium Iodine (131I) Drugs Sales Estimates and Forecasts 2021-2032
- 3.4 Global Sodium Iodine (131I) Drugs Sales by Region
- 3.4.1 Global Sodium Iodine (131I) Drugs Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Sodium Iodine (131I) Drugs Sales by Region (2021-2026)
- 3.4.3 Global Sodium Iodine (131I) Drugs Sales by Region (2027-2032)
- 3.4.4 Global Sodium Iodine (131I) Drugs Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Sodium Iodine (131I) Drugs Revenue by Manufacturers
- 4.1.1 Global Sodium Iodine (131I) Drugs Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Sodium Iodine (131I) Drugs Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Sodium Iodine (131I) Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Sodium Iodine (131I) Drugs Sales by Manufacturers
- 4.2.1 Global Sodium Iodine (131I) Drugs Sales by Manufacturers (2021-2026)
- 4.2.2 Global Sodium Iodine (131I) Drugs Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Sodium Iodine (131I) Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Sodium Iodine (131I) Drugs Sales Price by Manufacturers (2021-2026)
- 4.4 Global Sodium Iodine (131I) Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Sodium Iodine (131I) Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Sodium Iodine (131I) Drugs Manufacturers, Product Type & Application
- 4.7 Global Sodium Iodine (131I) Drugs Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Sodium Iodine (131I) Drugs Market CR5 and HHI
- 4.8.2 2025 Sodium Iodine (131I) Drugs Tier 1, Tier 2, and Tier 3
5 Sodium Iodine (131I) Drugs Market by Type
- 5.1 Global Sodium Iodine (131I) Drugs Revenue by Type
- 5.1.1 Global Sodium Iodine (131I) Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Sodium Iodine (131I) Drugs Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Sodium Iodine (131I) Drugs Revenue Market Share by Type (2021-2032)
- 5.2 Global Sodium Iodine (131I) Drugs Sales by Type
- 5.2.1 Global Sodium Iodine (131I) Drugs Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Sodium Iodine (131I) Drugs Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Sodium Iodine (131I) Drugs Sales Market Share by Type (2021-2032)
- 5.3 Global Sodium Iodine (131I) Drugs Price by Type
6 Sodium Iodine (131I) Drugs Market by Application
- 6.1 Global Sodium Iodine (131I) Drugs Revenue by Application
- 6.1.1 Global Sodium Iodine (131I) Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Sodium Iodine (131I) Drugs Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Sodium Iodine (131I) Drugs Revenue Market Share by Application (2021-2032)
- 6.2 Global Sodium Iodine (131I) Drugs Sales by Application
- 6.2.1 Global Sodium Iodine (131I) Drugs Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Sodium Iodine (131I) Drugs Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Sodium Iodine (131I) Drugs Sales Market Share by Application (2021-2032)
- 6.3 Global Sodium Iodine (131I) Drugs Price by Application
7 Company Profiles
- 7.1 Hta Co., Ltd
- 7.1.1 Hta Co., Ltd Company Information
- 7.1.2 Hta Co., Ltd Business Overview
- 7.1.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 7.1.5 Hta Co., Ltd Recent Developments
- 7.2 Yantai Dongcheng Biochemicals Co.,Ltd.
- 7.2.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
- 7.2.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
- 7.2.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 7.2.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
- 7.3 Chengdu Gaotong Isotope Co.,Ltd.
- 7.3.1 Chengdu Gaotong Isotope Co.,Ltd. Company Information
- 7.3.2 Chengdu Gaotong Isotope Co.,Ltd. Business Overview
- 7.3.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 7.3.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments
- 7.4 Mallinckrodt
- 7.4.1 Mallinckrodt Company Information
- 7.4.2 Mallinckrodt Business Overview
- 7.4.3 Mallinckrodt Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio
- 7.4.5 Mallinckrodt Recent Developments
- 7.5 Jubilant Radiopharma
- 7.5.1 Jubilant Radiopharma Company Information
- 7.5.2 Jubilant Radiopharma Business Overview
- 7.5.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio
- 7.5.5 Jubilant Radiopharma Recent Developments
- 7.6 International Isotopes
- 7.6.1 International Isotopes Company Information
- 7.6.2 International Isotopes Business Overview
- 7.6.3 International Isotopes Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 International Isotopes Sodium Iodine (131I) Drugs Product Portfolio
- 7.6.5 International Isotopes Recent Developments
- 7.7 BWXT Medical Ltd
- 7.7.1 BWXT Medical Ltd Company Information
- 7.7.2 BWXT Medical Ltd Business Overview
- 7.7.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 7.7.5 BWXT Medical Ltd Recent Developments
- 7.8 Bracco
- 7.8.1 Bracco Company Information
- 7.8.2 Bracco Business Overview
- 7.8.3 Bracco Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Bracco Sodium Iodine (131I) Drugs Product Portfolio
- 7.8.5 Bracco Recent Developments
- 7.9 AnazaoHealth
- 7.9.1 AnazaoHealth Company Information
- 7.9.2 AnazaoHealth Business Overview
- 7.9.3 AnazaoHealth Sodium Iodine (131I) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio
- 7.9.5 AnazaoHealth Recent Developments
8 North America
- 8.1 North America Sodium Iodine (131I) Drugs Market Size by Type
- 8.1.1 North America Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 8.1.2 North America Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 8.1.3 North America Sodium Iodine (131I) Drugs Price by Type (2021-2032)
- 8.2 North America Sodium Iodine (131I) Drugs Market Size by Application
- 8.2.1 North America Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 8.2.2 North America Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 8.2.3 North America Sodium Iodine (131I) Drugs Price by Application (2021-2032)
- 8.3 North America Sodium Iodine (131I) Drugs Market Size by Country
- 8.3.1 North America Sodium Iodine (131I) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Sodium Iodine (131I) Drugs Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Sodium Iodine (131I) Drugs Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Sodium Iodine (131I) Drugs Market Size by Type
- 9.1.1 Europe Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 9.1.2 Europe Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 9.1.3 Europe Sodium Iodine (131I) Drugs Price by Type (2021-2032)
- 9.2 Europe Sodium Iodine (131I) Drugs Market Size by Application
- 9.2.1 Europe Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 9.2.2 Europe Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 9.2.3 Europe Sodium Iodine (131I) Drugs Price by Application (2021-2032)
- 9.3 Europe Sodium Iodine (131I) Drugs Market Size by Country
- 9.3.1 Europe Sodium Iodine (131I) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Sodium Iodine (131I) Drugs Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Sodium Iodine (131I) Drugs Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Sodium Iodine (131I) Drugs Market Size by Type
- 10.1.1 China Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 10.1.2 China Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 10.1.3 China Sodium Iodine (131I) Drugs Price by Type (2021-2032)
- 10.2 China Sodium Iodine (131I) Drugs Market Size by Application
- 10.2.1 China Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 10.2.2 China Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 10.2.3 China Sodium Iodine (131I) Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Sodium Iodine (131I) Drugs Market Size by Type
- 11.1.1 Asia Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 11.1.2 Asia Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 11.1.3 Asia Sodium Iodine (131I) Drugs Price by Type (2021-2032)
- 11.2 Asia Sodium Iodine (131I) Drugs Market Size by Application
- 11.2.1 Asia Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 11.2.2 Asia Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 11.2.3 Asia Sodium Iodine (131I) Drugs Price by Application (2021-2032)
- 11.3 Asia Sodium Iodine (131I) Drugs Market Size by Country
- 11.3.1 Asia Sodium Iodine (131I) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Sodium Iodine (131I) Drugs Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Sodium Iodine (131I) Drugs Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Sodium Iodine (131I) Drugs Market Size by Type
- 12.1.1 SAMEA Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 12.1.2 SAMEA Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 12.1.3 SAMEA Sodium Iodine (131I) Drugs Price by Type (2021-2032)
- 12.2 SAMEA Sodium Iodine (131I) Drugs Market Size by Application
- 12.2.1 SAMEA Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 12.2.2 SAMEA Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 12.2.3 SAMEA Sodium Iodine (131I) Drugs Price by Application (2021-2032)
- 12.3 SAMEA Sodium Iodine (131I) Drugs Market Size by Country
- 12.3.1 SAMEA Sodium Iodine (131I) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Sodium Iodine (131I) Drugs Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Sodium Iodine (131I) Drugs Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Sodium Iodine (131I) Drugs Value Chain Analysis
- 13.1.1 Sodium Iodine (131I) Drugs Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Sodium Iodine (131I) Drugs Production Mode & Process
- 13.2 Sodium Iodine (131I) Drugs Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Sodium Iodine (131I) Drugs Distributors
- 13.2.3 Sodium Iodine (131I) Drugs Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst